查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1856327

粘合劑添加劑市場按類型、應用、形態和等級分類 - 全球預測 2025-2032

Binders Excipients Market by Type, Application, Form, Grade - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，粘合劑添加劑市場規模將達到 42.4 億美元，複合年成長率為 9.93%。

關鍵市場統計數據
基準年 2024 19.9億美元
預計年份：2025年 21.8億美元
預測年份 2032 42.4億美元
複合年成長率 (%) 9.93%

粘合劑輔料的策略方向，概述了粘合劑輔料在產品性能、可生產性和供應鏈韌性方面的多方面作用

粘合劑輔料能夠維持口服固體製劑和日益成長的營養補充品產品的機械完整性、可生產性和患者療效。這些材料的功能遠不止於簡單的黏合；它們還能調節粉末的流動性、可壓縮性、崩壞行為以及在各種加工條件下的穩定性。隨著配方日益複雜，製程強化也日益標準化，了解黏合劑的功能對於配方科學家和採購負責人都至關重要。

在製藥和營養保健品領域，粘合劑從早期研發到商業化都對製劑的選擇起著至關重要的作用。聚合物粘合劑與傳統澱粉基黏合劑的選擇會影響下游加工過程、壓片速度，甚至包衣性能。因此，粘合劑的選擇會影響品質設計框架、監管策略和成本控制。所以，評估黏合劑不僅要考慮其組成和等級，還要考慮其與活性成分、輔料和加工過程的相互作用。

材料科學和監管要求的最新變化導致人們對輔料的特性、可追溯性和供應商管治的審查日益嚴格。同時，連續加工和直接壓片等生產模式也對粘合劑的性能提出了新的功能性要求。本文將粘合劑輔料定位為策略性類別，其選擇和供應鏈管理對產品性能、上市時間和營運韌性有顯著影響。

技術創新、監管透明度和供應鏈韌性如何重塑粘合劑輔料的選擇和供應商策略

技術、監管和供應鏈的動態變化正在重塑粘合劑輔料的模式。聚合物化學和功能性澱粉改質技術的進步，使得粘合劑能夠提供可客製化的釋放曲線、更高的可壓縮性和更低的潤滑劑敏感性。同時，連續直接壓片和高通量壓片等生產製程的創新，也對黏合劑提出了更高的要求，即需要具有可預測流變性和穩定製程窗口的粘合劑。

監管機構對輔料來源的透明度和可追溯性提出了更高的要求，促使供應商加大投入，完善文件記錄、加強材料特性控制並進行第三方檢測。同時，對雜質譜和萃取物的審查力度也不斷加大，加速了製藥業對特性更明確的輔料等級的採用。因此，儘管不同地區的監管制度有所差異，但藥用級輔料和營養保健品級輔料之間的界限在實踐中變得越來越清晰。

供應鏈韌性已成為關鍵因素。供應鏈中斷凸顯了多元化籌資策略和供應商風險評估架構的必要性，這些策略和框架不僅限於價格和前置作業時間。負責人正在重新評估契約，篩選二手訊息，並尋求與能夠展現生產能力、品質系統和物流可靠性的供應商建立長期戰略夥伴關係。這些因素共同作用，正在重塑配方師和採購團隊評估粘合劑選擇的方式，使他們在優先考慮功能性能的同時，也重視法規遵循和供應連續性。

評估關稅調整和貿易政策轉變將如何改變裝訂機供應鏈的採購行為、供應商多元化和庫存策略。

關稅措施和貿易政策調整的推出將對粘合劑輔料生態系統產生深遠影響，波及原料成本、供應商籌資策略和庫存計畫。關稅往往會增加進口輔料的成本，迫使製造商重新評估其供應商網路並考慮在地採購方案。如果關稅出現不可預測的成長，則需要更頻繁地審查合約條款、前置作業時間和總到岸成本計算。

為應對關稅主導的成本壓力，製造商通常會透過供應商多元化來應對，納入國內生產商和自由貿易區合作夥伴，以減輕關稅的影響。雖然這種重組可以提高抗風險能力，但如果替代供應商採用不同的生產技術或原料，也可能導致輔料特性出現差異。因此，配方團隊必須投入資源進行過渡性開發活動和等效性測試，以確保替代不會影響片劑的完整性、溶出性能或穩定性。

關稅也影響庫存策略。企業可能會選擇策略性地儲備關鍵粘合劑等級，以應對短期成本波動，但這會帶來額外的營運成本和倉儲成本，以及保存期限管理方面的壓力。同時，採購部門正在重新談判長期契約，並與供應商探討避險機制，以緩解關稅不確定性的影響。這些調整的累積效應凸顯了在不斷變化的貿易環境下，企業需要進行商業性和技術決策的整合，以維持產品品質和利潤率。

利用整合的細分洞察，將黏合劑化學、應用方法、物理形態和品質等級相匹配，從而支持配方和採購決策。

對黏合劑細分的深入理解對於協調配方目標、生產平台和法規遵循至關重要。在考慮基於類型的選擇時，配方師會根據各種材料獨特的功能特性進行評估，例如藻酸鹽、纖維素衍生物、樹膠和凝膠、聚乙烯吡咯烷酮、澱粉以及醣類和多元醇。藻酸鹽具有獨特的水合和凝膠化行為，有利於控制釋放應用；纖維素衍生物因其穩定的壓縮性和成膜能力而備受青睞。聚乙烯吡咯烷酮也具有很強的乾膜和溶液黏合性能，使其適用於多種生產方法。澱粉仍然是一種用途廣泛的基準粘合劑，具有明顯的成本和生物分解性優勢；而醣類和多元醇通常在特定劑型中兼具粘合劑和調味輔料的雙重作用。

按應用領域進行細分會影響黏合劑的選擇和預期性能。直接壓片需要粘合劑能夠確保片劑的流動性、可壓縮性和強度，而無需額外的製粒步驟；而乾式製粒則需要能夠承受壓縮力並最大限度降低脆碎性的材料。濕式製粒引入了更多標準，因為粘合劑的溶解度、乾燥特性以及與活性成分的相互作用都會影響顆粒品質和後續加工。口服固態劑型包括膠囊和錠劑，每種劑型都有其獨特的崩壞和穩定性要求。膠囊著重於黏合劑與填充材的相互作用以及膠囊殼的完整性，而片劑則著重於壓片動態和包衣相容性。

劑型的選擇——粘合劑或液體粘合劑——會進一步影響研發路徑和設備選擇。乾粉黏合劑易於溶解於粉末混合物中，簡化了連續生產過程中的操作，但需要嚴格控制粒徑和水分含量。液體粘合劑常用於濕式製粒，以實現快速製粒和均勻分佈，但需要考慮溶劑處理和乾燥問題，這會影響製程產量和成本。最後，營養保健品級和藥品級黏合劑之間的差異會影響文件編制、品質系統和供應商資質認證的負擔。藥品級黏合劑需要嚴格的雜質控制、可靠的可追溯性以及符合藥典規範，而營養保健品級材料則具有更大的靈活性，但需要確保消費品的功能性能穩定可靠。

跨越這些細分市場需要跨部門協作。製劑科學家必須與採購、品質和法規團隊合作，確保黏合劑的選擇既滿足技術目標，又符合供應商的能力和合規承諾。等效性研究、小規模製程表徵和有記錄的供應商審核是管理不同類型、應用、劑型和等級產品交叉的實用工具，有助於制定一致的開發和生產計劃。

區域動態影響美洲、歐洲、中東和非洲以及亞太市場的黏合劑採購、法規遵循和製造夥伴關係關係

區域動態對粘合劑的採購、監管預期和生產策略有顯著影響。在美洲，成熟的製藥產業叢集將先進的生產能力與完善的法律規範相結合，從而促進了供應商和製造外包之間的密切合作。北美市場重視供應鏈透明度和嚴格的品管體系，並傾向選擇能夠展現長期生產能力和技術支援的供應商。拉丁美洲國家則呈現不同的動態，本地化生產不斷成長，對價格可負擔性和供應安全性的日益重視，迫使跨國公司相應地調整其採購和分銷策略。

歐洲、中東和非洲的監管協調和嚴格的藥典標準對輔料的文檔和可追溯性提出了高標準。歐洲市場通常在採用永續性標準和更嚴格的雜質控制方面處於領先地位，促使供應商投資於環保生產實踐和更先進的分析表徵技術。雖然中東和非洲部分地區仍然依賴進口來獲取特種粘合劑，但區域中心和自由貿易區的興起正在縮短鄰近市場的前置作業時間和降低關稅風險。這些區域差異要求供應商和製造商調整技術文件和物流安排，以滿足獨特的監管和商業需求。

亞太地區市場成熟度各異，同時擁有大規模的生產能力和創新的原料加工技術。該地區是傳統和新型黏合劑化學品的主要生產商所在地，為全球供應鏈提供具有成本競爭力的選擇，並加速了生物聚合物和改性澱粉技術的區域創新。各地區的法律規範差異顯著，在亞太地區營運的公司必須應對不同的註冊要求、標準和進口限制。這些區域特徵共同影響著公司如何優先考慮供應商資格、技術支援和本地生產夥伴關係，以實現成本效益和合規性。

透過具競爭力的供應商策略，結合技術合作、嚴格的品質系統和永續性資質，建立成功的配方和採購夥伴關係。

如今，粘合劑供應商之間的競爭動態主要圍繞著技術服務、品質保證和供應可靠性這三者。領先的製造商透過投資分析能力（例如顆粒表徵、流變分析和穩定性測試）來脫穎而出，從而支援複雜的配方開發並證明產品的可比性。提供應用實驗室和共同開發服務的供應商則可協助客戶縮短開發週期，並在新材料認證或更換供應商時降低風險。

品質系統和監管文件是至關重要的競爭因素。擁有全面分析證書、完善的變更控制流程和可驗證的供應商審核的公司，更有可能贏得與要求可追溯性和合規性的製藥公司簽訂的長期合約。同時，能夠提供從營養保健品到藥品等多種等級產品，並具有清晰品質區分的公司，更有利於服務多元化的客戶群。策略夥伴關係和長期供應協議日益普遍，反映出客戶對可預測的前置作業時間和緊急計畫的需求。

永續性和企業責任是新的競爭優勢。採用更環保的生產流程、減少溶劑使用並展現負責任的植物和澱粉原料採購方式的供應商，將吸引那些將環境因素納入採購決策的客戶。隨著採購機構加強對供應商的風險管理和環境考量，能夠將技術績效與永續性資格結合的公司將獲得競爭優勢。此外，對於希望服務全球客戶的供應商而言，能夠擴大生產規模以支援小批量創新和大量商業供應的能力仍然至關重要。

管治可採取切實可行的策略步驟，以協調技術能力、供應商多元化和治理框架，從而確保裝訂機的供應和產品品質。

產業領導者應優先考慮整合策略，將技術開發、供應商多元化和監管回應協調一致。這首先要實施跨職能的粘合劑管治框架，將配方科學家、品質保證、採購和法規事務部門納入同一個決策流程。這種方法可以降低引入替代供應商時出現下游意外情況的風險，並透過並行測試和文件共用來加快核准速度。

投資分析和應用支援能力會帶來豐厚的回報。建立內部或合作實驗室，用於流變學、粒徑分佈和壓實分析，可以快速進行等效性測試，並加速規模化生產。將技術投資與基於情境的採購計畫結合，評估供應商能力、雙重採購方案和物流應急措施，可以緩解貿易政策波動和產能限制的影響。這些綜合措施有助於在保持配方性能的同時，維持供應的連續性。

採用獎勵透明度和持續改進的供應商合作模式。優先考慮那些發布高品質文件、參與聯合開發計劃並致力於永續性改進的供應商。盡可能協商靈活的商業條款，其中包含品質保證、合約變更控制和聯合規劃條款。最後，在產品開發策略的早期階段就考慮粘合劑，以充分利用配方協同效應，減少後期替代，並確保供應鏈決策支援產品的長期性能和合規性目標。

透過結合相關人員訪談、技術文獻綜合和供應商能力評估的混合研究途徑，獲得可靠的見解。

本研究綜合分析基於一套結構化的方法，整合了相關人員訪談、技術文獻綜述和供應商能力評估，從而提供嚴謹且可操作的分析。主要資訊來源包括與配方科學家、採購負責人和法規專家的討論，他們的營運見解有助於解讀材料功能、合格困難和籌資策略。這些定性資訊與黏合劑化學的技術文獻、生產案例研究和官方法規指南進行了交叉比對，以確保研究結果建立在堅實的技術基礎之上。

供應商能力評估著重於生產流程、品管體係以及應用支援服務的可用性。在適用情況下，我們會審查審核和製造商文檔，以檢驗可追溯性實務以及是否符合相關藥典標準。該調查方法還納入了情境分析，以探討供應中斷或政策變化對營運的影響，並提案切實可行的緩解措施。

在整個過程中，我們將重點放在可重複的評估標準，包括功能績效指標、監管準備指標和供應鏈韌性指標。這種混合方法確保了所提出的見解既具有技術上的合理性，又能直接應用於商業性決策和製劑開發規劃。

最終整合方案將粘合劑輔料定位為跨職能優先事項，連接製劑性能、籌資策略和供應鏈彈性。

粘合劑輔料是一類策略性材料，其選擇會影響配方性能、製程效率、法規遵循和供應鏈韌性。此外，營養保健品級和藥品級輔料的差異決定了其所需的文件和供應商資質要求也不同。企業若能將技術評估與籌資策略和法規計畫結合，便可降低風險並加快產品上市速度。

不斷變化的市場環境要求配方團隊和採購團隊之間加強協作，增加對分析能力的投入，並積極主動地與供應商溝通，並專注於透明度和產能保障。區域動態和貿易政策的轉變進一步凸顯了多元化籌資策略和基於情境的庫存規劃的必要性。綜上所述，這些結論指向一個切實可行的目標：將黏合劑輔料視為跨職能部門的優先事項，而非單純的商品採購，並在產品開發流程的早期階段就對其進行評估，以確保其性能和供應的連續性。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 對源自可再生資源的天然聚合物粘合劑的需求不斷成長，以滿足永續配方的需求。
  • 噴霧乾燥澱粉作為多功能粘合劑在直接壓片中的應用日益廣泛。
  • 人們對微晶纖維素在高速片劑生產中提高可壓縮性的興趣日益濃厚
  • 開發多功能共加工粘合劑輔料以取代片劑中的單功能粘合劑
  • 將有機酸改質粘合劑整合到片劑中，以改善片劑的崩壞和溶出性能。
  • 擴大不含染料和過敏原的藥用粘合劑配方，以滿足不斷變化的監管要求
  • 改進粘合劑和輔料，以實現製藥生產線上的連續生產
  • 利用奈米工程粘合劑輔料最佳化控制釋放片劑藥物釋放曲線的研究與開發正在興起。
  • 預測粘合劑性能的建模軟體的出現，簡化了配方開發流程，減少了試驗失敗。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章粘合劑添加劑市場（按類型分類）

  • 海藻酸鹽
  • 纖維素衍生物
  • 口香糖和凝膠
  • 聚乙烯吡咯烷酮
  • 澱粉
  • 醣類和多元醇

第9章 按應用分類的粘合劑添加劑市場

  • 直接壓片
  • 乾式製粒
  • 口服固體製劑
    • 膠囊
    • 藥片
  • 濕式製粒

第10章 依形態分類的粘合劑市場

  • 乾燥黏合劑
  • 液體黏合劑

第11章粘合劑市場（按等級分類）

  • 營養補充品
  • 製藥

第12章 各地區粘合劑添加劑市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章粘合劑添加劑市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國粘合劑添加劑市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • International Flavors & Fragrances Inc.
    • Roquette Freres SA
    • Ashland Inc.
    • BASF SE
    • JRS Pharma GmbH & Co. KG
    • DFE Pharma NV
    • Merck KGaA
    • Shin-Etsu Chemical Co., Ltd.
    • Kerry Group plc
    • Ingredion Incorporated
Product Code: MRR-742BD517BD05

The Binders Excipients Market is projected to grow by USD 4.24 billion at a CAGR of 9.93% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.99 billion
Estimated Year [2025] USD 2.18 billion
Forecast Year [2032] USD 4.24 billion
CAGR (%) 9.93%

A strategic orientation to binder excipients that outlines their multifaceted roles in product performance, manufacturability, and supply chain resilience

Binder excipients underpin the mechanical integrity, manufacturability, and patient performance of oral solid dosage forms and a growing range of nutraceutical products. These materials function beyond simple adhesion; they mediate powder flow, compressibility, disintegration behavior, and stability under varied processing conditions. With formulation complexity increasing and process intensification becoming standard, understanding binder functionality is essential for both formulation scientists and sourcing professionals.

Across pharmaceutical and nutraceutical contexts, binders influence formulation selection from early development through commercialization. The choice between polymeric binders and traditional starch-based systems drives downstream process settings, tableting speeds, and even coating behavior. Consequently, binder selection has ripple effects across quality by design frameworks, regulatory strategy, and cost management. Practitioners must therefore evaluate binders not only by composition and grade but by how they interact with active ingredients, excipients, and processing technologies.

Recent shifts in material science and regulatory expectations have intensified scrutiny on excipient characterization, traceability, and supplier governance. Simultaneously, manufacturing paradigms such as continuous processing and direct compression place new functional demands on binder performance. This introduction frames binder excipients as a strategic category whose selection and supply chain management materially affect product performance, time to market, and operational resilience.

How technological innovation, regulatory transparency, and supply chain resilience are jointly reshaping binder excipient selection and supplier strategies

The landscape for binder excipients is experiencing transformative shifts driven by technological, regulatory, and supply chain dynamics. Advances in polymer chemistry and functional starch modification are enabling binders that deliver tailored release profiles, improved compressibility, and reduced lubricant sensitivity. At the same time, manufacturing innovation-such as continuous direct compression and high-throughput tableting-demands binders with predictable rheology and robust process windows.

Regulatory expectations are shifting toward greater transparency and traceability for excipient sourcing, prompting suppliers to invest in enhanced documentation, controlled material attributes, and third-party testing. This trend is paralleled by increasing scrutiny of impurity profiles and leachables, which in turn has accelerated the adoption of more rigorously characterized grades for pharmaceutical applications. As a result, the boundary between pharmaceutical-grade and nutraceutical-grade excipients is becoming more defined in practice, even if regulatory regimes differ by jurisdiction.

Supply chain resilience has emerged as a decisive factor. Disruptions have highlighted the need for diversified sourcing strategies and supplier risk assessment frameworks that extend beyond price and lead time. Companies are re-evaluating contracts, qualifying secondary sources, and seeking longer-term strategic partnerships with suppliers that can demonstrate capacity, quality systems, and logistical reliability. These combined forces are reshaping how formulators and procurement teams evaluate binder choices, prioritizing functional performance alongside regulatory readiness and supply continuity.

Assessing how tariff adjustments and trade policy shifts reshape sourcing behaviors, supplier diversification, and inventory strategies across binder supply chains

The introduction of tariff measures and trade policy adjustments can have wide-ranging effects on the binder excipient ecosystem, affecting raw material costs, supplier sourcing strategies, and inventory planning. Tariffs tend to raise the cost base for imported excipients, which in turn pressures manufacturers to reassess supplier networks and examine local sourcing alternatives. When customs duties increase unpredictably, contract terms, lead times, and total landed cost calculations require more frequent revision.

Manufacturers often respond to tariff-driven cost pressures by diversifying supplier footprints to include domestic producers or free trade zone partners that mitigate duty exposure. This reconfiguration can improve resilience but may also introduce variability in excipient attributes if alternate suppliers use different production technologies or raw materials. As a result, formulation teams must invest in bridging development activities and equivalence testing to ensure that substitutions do not compromise tablet integrity, dissolution performance, or stability.

Tariffs also influence inventory strategies. Companies may opt for strategic stockpiling of critical binder grades to buffer against short-term cost volatility, but this creates additional working capital and storage considerations as well as shelf-life management obligations. In parallel, procurement functions are renegotiating long-term agreements and exploring hedging mechanisms with suppliers to smooth the impact of tariff unpredictability. These cumulative adjustments highlight the need for integrated commercial and technical decision-making to preserve both product quality and margin under shifting trade conditions.

Integrated segmentation insights that align binder chemistries, application methodologies, physical forms, and quality grades to support formulation and sourcing decisions

A nuanced understanding of binder segmentation is essential for aligning formulation goals, manufacturing platforms, and regulatory compliance. When considering type-based selection, formulators evaluate materials such as alginates, cellulose derivatives, gums and gels, polyvinylpyrrolidone, starch, and sugars and polyols for their distinct functional attributes. Alginates offer unique hydration and gelation behaviors beneficial for controlled-release applications, while cellulose derivatives are valued for consistent compressibility and film-forming capacity. Gums and gels can impart viscosity and binding under moist granulation regimes, and polyvinylpyrrolidone provides strong dry binding and solution-binding properties that suit diverse manufacturing methods. Starch remains a versatile baseline binder with clear advantages in cost and biodegradability, whereas sugars and polyols often serve dual roles as binders and taste-modifying excipients in certain dose forms.

Application-driven segmentation influences both selection and performance expectations. Direct compression demands binders that support flow, compressibility, and tablet strength without additional granulation steps, whereas dry granulation requires materials that withstand compaction forces and minimize friability. Wet granulation introduces a separate set of criteria where the binder's solubility, drying profile, and interaction with active ingredients affect granule quality and downstream processing. Oral solid dosage forms span capsule and tablet presentations, each with unique disintegration and stability requirements; capsule formulations place greater emphasis on binder interaction with fill material and capsule shell integrity, while tablet formats focus on compaction dynamics and coating compatibility.

Form selection-dry binder versus liquid binder-further shapes development pathways and equipment choices. Dry binders integrate readily into powder blends and simplify handling for continuous processing, but they may require careful control of particle size and moisture content. Liquid binders are often used in wet granulation to achieve rapid granule formation and uniform distribution, though they introduce solvent handling and drying considerations that can affect process throughput and cost. Finally, grade differentiation between nutraceutical and pharmaceutical influences documentation, quality systems, and supplier qualification burdens. Pharmaceutical-grade binders necessitate tighter control over impurities, robust traceability, and adherence to pharmacopoeial standards, while nutraceutical-grade materials may permit more flexibility but still require consistent functional performance for consumer-facing products.

Transitioning across these segmentation axes requires cross-functional collaboration. Formulation scientists must work alongside procurement, quality, and regulatory teams to ensure that binder selection meets technical objectives while aligning with supplier capabilities and compliance commitments. Equivalence studies, small-scale process characterization, and documented supplier audits are practical tools to manage the intersection of type, application, form, and grade in a cohesive development and manufacturing plan.

Regional dynamics that shape binder sourcing, regulatory conformity, and manufacturing partnerships across the Americas, Europe Middle East Africa, and Asia-Pacific markets

Regional dynamics exert a strong influence on binder sourcing, regulatory expectations, and manufacturing strategy. In the Americas, established pharmaceutical clusters combine advanced manufacturing capabilities with mature regulatory frameworks, enabling close collaboration between suppliers and contract manufacturers. North American markets emphasize supply chain transparency, rigorous quality management systems, and a preference for suppliers that can demonstrate long-term capacity and technical support. Latin American countries present different dynamics, with increasing local manufacturing and a growing emphasis on affordability and supply security, prompting multinational companies to adapt procurement and distribution strategies accordingly.

Across Europe, the Middle East & Africa, regulatory harmonization and stringent pharmacopoeial standards set high bars for excipient documentation and traceability. European markets often lead in the adoption of sustainability criteria and stricter impurity controls, influencing supplier investments in greener manufacturing practices and enhanced analytical characterization. In parts of the Middle East and Africa, reliance on imports for specialized binder grades continues, but regional hubs and free trade zones are emerging that can reduce lead times and tariff exposure for nearby markets. These regional nuances require suppliers and manufacturers to calibrate their technical dossiers and logistical arrangements to meet distinctive regulatory and commercial expectations.

Asia-Pacific combines diverse market maturity levels with large-scale manufacturing capacity and innovation in raw material processing. Major producers of traditional and novel binder chemistries are located in this region, supplying global supply chains with cost-competitive options while also accelerating local innovation in biopolymers and modified starch technologies. Regional regulatory frameworks vary considerably, and companies operating across Asia-Pacific must navigate differing registration requirements, standards, and import controls. Together, these regional characteristics shape how companies prioritize supplier qualification, technical support, and local manufacturing partnerships to achieve both cost efficiency and regulatory compliance.

Competitive supplier strategies that combine technical co-development, stringent quality systems, and sustainability credentials to win formulation and procurement partnerships

Competitive dynamics among binder suppliers now centers on a combination of technical service, quality assurance, and supply reliability. Leading manufacturers differentiate through investments in analytical capabilities, such as particle characterization, rheological profiling, and stability testing, which enable them to support complex formulation development and equivalence demonstrations. Suppliers that offer application laboratories and co-development services help customers shorten development cycles and reduce risk when qualifying new materials or switching sources.

Quality systems and regulatory documentation are critical competitive levers. Firms that maintain comprehensive certificates of analysis, robust change control processes, and demonstrable supplier audits tend to win longer-term contracts with pharmaceutical customers who require traceability and compliance. In parallel, companies that can provide multiple grades-spanning nutraceutical to pharmaceutical-with clear quality delineation are well-positioned to serve diverse client segments. Strategic partnerships and long-term supply agreements are increasingly common, reflecting customer demand for predictable lead times and contingency planning.

Sustainability and corporate responsibility are emerging differentiators. Suppliers that adopt greener manufacturing processes, reduce solvent use, and demonstrate responsible sourcing of botanical and starch feedstocks appeal to customers who incorporate environmental criteria into procurement decisions. As procurement organizations elevate supplier risk management and environmental considerations, firms that can align technical performance with sustainability credentials secure competitive advantage. Moreover, the ability to scale production to support both small-batch innovation work and high-volume commercial supply remains a critical capability for suppliers seeking to serve global customers.

Actionable strategic steps for leaders to align technical capability, supplier diversification, and governance frameworks to secure binder availability and product quality

Industry leaders should prioritize an integrated strategy that aligns technical development, supplier diversification, and regulatory readiness. Begin by implementing a cross-functional binder governance framework that brings formulation scientists, quality assurance, procurement, and regulatory affairs into a single decision-making loop. This approach reduces the risk of downstream surprises when substitute suppliers are introduced and accelerates qualification timelines through concurrent testing and documentation sharing.

Investments in analytical and application support capabilities pay dividends. Establishing in-house or collaborative labs for rheology, particle size distribution, and compaction analysis enables rapid equivalence testing and accelerates scale-up. Pair technical investments with scenario-based procurement planning that evaluates supplier capacity, dual-sourcing options, and logistics contingencies to mitigate trade policy volatility and capacity constraints. These combined measures help maintain continuity of supply while preserving formulation performance.

Adopt a supplier engagement model that rewards transparency and continuous improvement. Prefer suppliers who publish robust quality documentation, participate in joint development projects, and commit to sustainability improvements. Where possible, negotiate flexible commercial terms that incorporate quality guarantees, contractual change control, and collaborative planning provisions. Finally, incorporate binder considerations early in product development strategies to exploit formulation synergies, reduce late-stage substitutions, and ensure that supply chain decisions support long-term product performance and compliance objectives.

A mixed-method research approach combining stakeholder interviews, technical literature synthesis, and supplier capability assessments for dependable insights

This research synthesis relies on a structured methodology that integrates primary stakeholder interviews, technical literature review, and supplier capability assessments to produce a rigorous, actionable analysis. Primary inputs included discussions with formulation scientists, procurement leads, and regulatory specialists whose operational insights informed the interpretation of material functionality, qualification hurdles, and sourcing strategies. These qualitative inputs were triangulated with technical literature on binder chemistry, manufacturing case studies, and public regulatory guidance to ensure findings are grounded in robust technical context.

Supplier capability assessments focused on production processes, quality management systems, and the availability of application support services. Where applicable, audits and manufacturer documentation were reviewed to verify traceability practices and conformity with relevant pharmacopoeial standards. The methodology also incorporated scenario analysis to explore the operational impacts of supply disruptions and policy shifts, enabling the development of practical mitigation recommendations.

Throughout the process, an emphasis was placed on reproducible evaluation criteria such as functional performance metrics, regulatory readiness indicators, and supply chain resilience measures. This mixed-method approach ensures that the insights presented are both technically defensible and directly applicable to commercial decision-making and formulation development planning.

Concluding synthesis that positions binder excipients as a cross-functional priority linking formulation performance, procurement strategy, and supply chain resilience

Binder excipients represent a strategic category whose selection affects formulation performance, process efficiency, regulatory compliance, and supply chain resilience. Functional differentiation across binder chemistries and forms creates meaningful implications for manufacturing platforms such as direct compression, wet granulation, and dry granulation, while grade differentiation between nutraceutical and pharmaceutical uses alters documentation and supplier qualification demands. Companies that align technical evaluation with procurement strategy and regulatory planning can reduce risk and accelerate time to market.

The evolving landscape calls for closer collaboration between formulation and procurement teams, deeper investment in analytical capabilities, and proactive supplier engagement that emphasizes transparency and capacity assurance. Regional dynamics and trade policy shifts further underline the necessity of diversified sourcing strategies and scenario-based inventory planning. Taken together, these conclusions point to a single practical imperative: treat binder excipients as a cross-functional priority rather than a purely commodity purchase, and embed their evaluation early in product development workflows to secure performance and supply continuity.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising demand for natural polymer binders derived from renewable resources for sustainable formulations
  • 5.2. Increasing adoption of spray-dried starch as multifunctional binder in direct compression tablet processes
  • 5.3. Growing focus on microcrystalline cellulose variants with enhanced compressibility in high-speed tablet manufacturing
  • 5.4. Development of multifunctional coprocessed binder excipients to replace single-function binding agents in tablets
  • 5.5. Integration of organic acid modified binder excipients to improve tablet disintegration and dissolution performance
  • 5.6. Expansion of pharmaceutical dye-free and allergen-free binder formulations to meet evolving regulatory requirements
  • 5.7. Advancement of binder excipient formulations enabling continuous manufacturing in pharmaceutical production lines
  • 5.8. Surge in R&D for nanoengineered binder excipients to optimize drug release profiles in controlled release tablets
  • 5.9. Emergence of predictive modeling software for binder performance to streamline formulation development and reduce trial failures

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Binders Excipients Market, by Type

  • 8.1. Alginates
  • 8.2. Cellulose Derivatives
  • 8.3. Gums And Gels
  • 8.4. Polyvinylpyrrolidone
  • 8.5. Starch
  • 8.6. Sugars And Polyols

9. Binders Excipients Market, by Application

  • 9.1. Direct Compression
  • 9.2. Dry Granulation
  • 9.3. Oral Solid Dosage
    • 9.3.1. Capsule
    • 9.3.2. Tablet
  • 9.4. Wet Granulation

10. Binders Excipients Market, by Form

  • 10.1. Dry Binder
  • 10.2. Liquid Binder

11. Binders Excipients Market, by Grade

  • 11.1. Nutraceutical
  • 11.2. Pharmaceutical

12. Binders Excipients Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Binders Excipients Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Binders Excipients Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. International Flavors & Fragrances Inc.
    • 15.3.2. Roquette Freres SA
    • 15.3.3. Ashland Inc.
    • 15.3.4. BASF SE
    • 15.3.5. JRS Pharma GmbH & Co. KG
    • 15.3.6. DFE Pharma N.V.
    • 15.3.7. Merck KGaA
    • 15.3.8. Shin-Etsu Chemical Co., Ltd.
    • 15.3.9. Kerry Group plc
    • 15.3.10. Ingredion Incorporated

LIST OF FIGURES

  • FIGURE 1. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS BINDERS EXCIPIENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BINDERS EXCIPIENTS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. BINDERS EXCIPIENTS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BINDERS EXCIPIENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY ALGINATES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY ALGINATES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY ALGINATES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY ALGINATES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY ALGINATES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY ALGINATES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY GUMS AND GELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY GUMS AND GELS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY GUMS AND GELS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY GUMS AND GELS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY GUMS AND GELS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY GUMS AND GELS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY POLYVINYLPYRROLIDONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY POLYVINYLPYRROLIDONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY POLYVINYLPYRROLIDONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY POLYVINYLPYRROLIDONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY POLYVINYLPYRROLIDONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY POLYVINYLPYRROLIDONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY STARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY STARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY STARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY STARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY STARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY STARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYOLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYOLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYOLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYOLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYOLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYOLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY DIRECT COMPRESSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY DIRECT COMPRESSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY DIRECT COMPRESSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY DIRECT COMPRESSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY DIRECT COMPRESSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY DIRECT COMPRESSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY DRY GRANULATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY DRY GRANULATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY DRY GRANULATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY DRY GRANULATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY DRY GRANULATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY DRY GRANULATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY CAPSULE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY CAPSULE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY CAPSULE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY CAPSULE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY CAPSULE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY TABLET, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY TABLET, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY TABLET, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY TABLET, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY TABLET, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY WET GRANULATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY WET GRANULATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY WET GRANULATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY WET GRANULATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY WET GRANULATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY WET GRANULATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY DRY BINDER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY DRY BINDER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY DRY BINDER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY DRY BINDER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY DRY BINDER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY DRY BINDER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY LIQUID BINDER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY LIQUID BINDER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY LIQUID BINDER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY LIQUID BINDER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY LIQUID BINDER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY LIQUID BINDER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY NUTRACEUTICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY NUTRACEUTICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY NUTRACEUTICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY NUTRACEUTICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY NUTRACEUTICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY NUTRACEUTICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY PHARMACEUTICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY PHARMACEUTICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY PHARMACEUTICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY PHARMACEUTICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. AMERICAS BINDERS EXCIPIENTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 114. AMERICAS BINDERS EXCIPIENTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 115. AMERICAS BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 116. AMERICAS BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 117. AMERICAS BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 118. AMERICAS BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 119. AMERICAS BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 120. AMERICAS BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 121. AMERICAS BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 122. AMERICAS BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 123. AMERICAS BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
  • TABLE 124. AMERICAS BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2025-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. NORTH AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 128. NORTH AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 130. NORTH AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 132. NORTH AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 134. NORTH AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
  • TABLE 136. NORTH AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2025-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. LATIN AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 140. LATIN AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 142. LATIN AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 144. LATIN AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 146. LATIN AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
  • TABLE 148. LATIN AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2025-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2025-2032 (USD MILLION)
  • TABLE 161. EUROPE BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. EUROPE BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. EUROPE BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 164. EUROPE BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 165. EUROPE BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 166. EUROPE BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 167. EUROPE BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 168. EUROPE BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 169. EUROPE BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 170. EUROPE BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 171. EUROPE BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
  • TABLE 172. EUROPE BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2025-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. MIDDLE EAST BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. MIDDLE EAST BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 178. MIDDLE EAST BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 180. MIDDLE EAST BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 182. MIDDLE EAST BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
  • TABLE 184. MIDDLE EAST BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2025-2032 (USD MILLION)
  • TABLE 185. AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 189. AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 190. AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 191. AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 192. AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 193. AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 194. AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 195. AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
  • TABLE 196. AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2025-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 206. ASIA-PACIFIC BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. ASEAN BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. ASEAN BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. ASEAN BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. ASEAN BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 215. ASEAN BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 216. ASEAN BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 217. ASEAN BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 218. ASEAN BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 219. ASEAN BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 220. ASEAN BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 221. ASEAN BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
  • TABLE 222. ASEAN BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2025-2032 (USD MILLION)
  • TABLE 223. GCC BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GCC BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. GCC BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. GCC BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 227. GCC BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 228. GCC BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 229. GCC BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 230. GCC BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 231. GCC BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 232. GCC BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 233. GCC BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
  • TABLE 234. GCC BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPEAN UNION BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPEAN UNION BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPEAN UNION BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPEAN UNION BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPEAN UNION BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPEAN UNION BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPEAN UNION BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPEAN UNION BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPEAN UNION BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPEAN UNION BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPEAN UNION BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2025-2032 (USD MILLION)
  • TABLE 247. BRICS BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. BRICS BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. BRICS BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. BRICS BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. BRICS BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 252. BRICS BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 253. BRICS BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 254. BRICS BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 255. BRICS BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 256. BRICS BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 257. BRICS BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
  • TABLE 258. BRICS BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2025-2032 (USD MILLION)
  • TABLE 259. G7 BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. G7 BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. G7 BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. G7 BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 263. G7 BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 264. G7 BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 265. G7 BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 266. G7 BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 267. G7 BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 268. G7 BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 269. G7 BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
  • TABLE 270. G7 BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2025-2032 (USD MILLION)
  • TABLE 271. NATO BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. NATO BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. NATO BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. NATO BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 275. NATO BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 276. NATO BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 277. NATO BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 278. NATO BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 279. NATO BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 280. NATO BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 281. NATO BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
  • TABLE 282. NATO BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 285. UNITED STATES BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. UNITED STATES BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 287. UNITED STATES BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 288. UNITED STATES BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 289. UNITED STATES BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 290. UNITED STATES BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 291. UNITED STATES BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 292. UNITED STATES BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 293. UNITED STATES BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
  • TABLE 294. UNITED STATES BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2025-2032 (USD MILLION)
  • TABLE 295. CANADA BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 296. CANADA BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 297. CANADA BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 298. CANADA BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 299. CANADA BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 300. CANADA BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 301. CANADA BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 302. CANADA BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 303. CANADA BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
  • TABLE 304. CANADA BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2025-2032 (USD MILLION)
  • TABLE 305. MEXICO BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 306. MEXICO BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 307. MEXICO BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 308. MEXICO BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 309. MEXICO BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 310. MEXICO BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 311. MEXICO BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 312. MEXICO BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 313. MEXICO BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
  • TABLE 314. MEXICO BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2025-2032 (USD MILLION)
  • TABLE 315. BRAZIL BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. BRAZIL BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 317. BRAZIL BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 318. BRAZIL BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 319. BRAZIL BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 320. BRAZIL BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 321. BRAZIL BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 322. BRAZIL BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 323. BRAZIL BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
  • TABLE 324. BRAZIL BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2025-2032 (USD MILLION)
  • TABLE 325. UNITED KINGDOM BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 326. UNITED KINGDOM BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 327. UNITED KINGDOM BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 328. UNITED KINGDOM BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 329. UNITED KINGDOM BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 330. UNITED KINGDOM BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 331. UNITED KINGDOM BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 332. UNITED KINGDOM BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 333. UNITED KINGDOM BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
  • TABLE 334. UNITED KINGDOM BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2025-2032 (USD MILLION)
  • TABLE 335. GERMANY BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 336. GERMANY BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 337. GERMANY BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 338. GERMANY BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 339. GERMANY BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 340. GERMANY BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 341. GERMANY BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 342. GERMANY BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 343. GERMANY BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
  • TABLE 344. GERMANY BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2025-2032 (USD MILLION)
  • TABLE 345. FRANCE BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 346. FRANCE BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 347. FRANCE BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 348. FRANCE BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 349. FRANCE BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 350. FRANCE BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 351. FRANCE BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 352. FRANCE BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 353. FRANCE BINDE